Spruce BioSciences

IPO

Novel Therapies for Rare Endocrine Disorders

Spruce BioSciences is a biotech company in South San Francisco, United States, founded in 2016. It has raised $138.0M across 3 rounds, most recently an $88.0M Series B in February 2020.

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$138.0M
Last Round
$88.0M Series BFeb 2020
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. to use credits for reveals, or explore the API.

About

Spruce BioSciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine and neurological disorders. Headquartered in South San Francisco, California, the company targets underserved patient populations with significant unmet medical needs.

Funding & Exit History

Data from Indexed.vcUpdated
IPOOct 2020
$90.0M

3 more funding events

  • Series B20203 investors
  • Series A20172 investors
  • Venture Round

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Spruce BioSciences on Indexed.vc
<a href="https://indexed.vc/companies/spruce-biosciences"><img src="https://indexed.vc/api/badge/company/spruce-biosciences" alt="Spruce BioSciences on Indexed.vc" width="260" height="76" /></a>